ARID5B regulates metabolic programming in human adaptive NK cells

Author:

Cichocki Frank1,Wu Cheng-Ying1,Zhang Bin1ORCID,Felices Martin1,Tesi Bianca23,Tuininga Katie1,Dougherty Phillip1,Taras Emily1,Hinderlie Peter1,Blazar Bruce R.4ORCID,Bryceson Yenan T.56ORCID,Miller Jeffrey S.1ORCID

Affiliation:

1. Department of Medicine, University of Minnesota, Minneapolis, MN

2. Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden

3. Clinical Genetics Unit, Department of Molecular Medicine and Surgery, and Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden

4. Department of Pediatrics, University of Minnesota, Minneapolis, MN

5. Centre for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden

6. Broegelmann Research Laboratory, Department of Clinical Sciences, University of Bergen, Bergen, Norway

Abstract

Natural killer (NK) cells with adaptive immunological properties expand and persist in response to human cytomegalovirus. Here, we explored the metabolic processes unique to these cells. Adaptive CD3−CD56dimCD57+NKG2C+ NK cells exhibited metabolic hallmarks of lymphocyte memory, including increased oxidative mitochondrial respiration, mitochondrial membrane potential, and spare respiratory capacity. Mechanistically, we found that a short isoform of the chromatin-modifying transcriptional regulator, AT-rich interaction domain 5B (ARID5B), was selectively induced through DNA hypomethylation in adaptive NK cells. Knockdown and overexpression studies demonstrated that ARID5B played a direct role in promoting mitochondrial membrane potential, expression of genes encoding electron transport chain components, oxidative metabolism, survival, and IFN-γ production. Collectively, our data demonstrate that ARID5B is a key regulator of metabolism in human adaptive NK cells, which, if targeted, may be of therapeutic value.

Funder

National Institutes of Health

European Research Council

Swedish Research Council

Norwegian Research Council

Swedish Foundation for Strategic Research

Wallenberg Foundation

Swedish Cancer Foundation

Swedish Childhood Cancer Foundation

Stockholm County Council

Karolinska Institutet

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

Cited by 93 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3